SIM Life Sciences

SIM Life Sciences focuses on financial and strategic opportunities in the life sciences space.

We leverage the relationships that Dr. Colin Bristow (former head of UBS Healthcare and BioPharma investor at Citadel and Millennium) and our team have built up over the last 15 years to identify underappreciated opportunities and/or where the team can create value. We believe we are better positioned to identify and execute on these opportunities given our deep industry knowledge, strong network and deal structuring experience. We understand the critical role that IP plays in these opportunities, where we also have world-renowned expertise. We are opportunistic, nimble and able to be creative with deal structures (participating in various levels of the capital structure), allowing us to maximize value creation for SIM Life Sciences and its targets.